Influenzinum (Energique, Inc.)


Welcome to the PulseAid listing for the Influenzinum drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Energique, Inc.
NON-PROPRIETARY NAME: Influenzinum (2017-2018)
SUBSTANCE NAME: INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VI
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2017-09-29
END MARKETING DATE: 0000-00-00


Influenzinum HUMAN OTC DRUG Details:

Item DescriptionInfluenzinum from Energique, Inc.
LABELER NAME: Energique, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 200; 200; 200([hp_C]/mL; [hp_C]/mL; [hp_C]/mL)
START MARKETING DATE: 2017-09-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44911-0444_add108ce-603f-424b-b8ce-0ed2f3d461b4
PRODUCT NDC: 44911-0444
APPLICATION NUMBER:

Other INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VI Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Energique, Inc.Influenzinum
Ratis, LLCInfluenzinum
Seqirus Pty LtdAFLURIA